Vivani Medical Inc. Common Stock VANI · Stock Open Vivani Medical Inc. Common Stock in new tab
Vivani Medical Inc. Common Stock Analysis (VANI)
Is Vivani Medical Inc. Common Stock a good investment? Vivani Medical Inc. Common Stock (VANI) is currently trading at 1.30 USD. Market analysts have a consensus price target of 3.83 USD. This suggests a potential upside from current levels.
Earnings Schedule: Vivani Medical Inc. Common Stock is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -0.35.
Investor FAQ
Does Vivani Medical Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Vivani Medical Inc. Common Stock?
Vivani Medical Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -0.36.
Company Profile
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 6, 2020 | 1:8 |
| Aug. 19, 2022 | 1:3 |
Community Discussion